Development of a Nanobody–Alkaline Phosphatase Fusion Protein for Detection of SARS-CoV-2 Spike Protein in a Fluorescence Enzyme Immunoassay
Analytical Chemistry · 2024
DOI: 10.1021/acs.analchem.4c04799 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2024. Verfasst von Heng Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Stomatology, Hospital of Stomatology/Guangxi Key Laboratory of Nanobody Research/Guangxi Nanobody Engineering Research Center/School of Ba…. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, Alkaline Phosphatase, SARS-CoV-2, Single-Domain Antibodies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Specific Research Project of Guangxi for Research Bases and Talents, National Natural Science Foundation of China, Guangxi Key Laboratory of Nanobody Research.
Abstract (Originalsprache)
The continuous spread and evolution of severe acute respiratory symptom coronavirus 2 (SARS-CoV-2) necessitate the development of convenient and rapid detection methods. In this study, we developed a fluorescence enzyme immunoassay (FEIA) based on a nanobody (Nb)-alkaline phosphatase (ALP) fusion protein for detection of SARS-CoV-2 spike protein. The genetically modified anti-SARS-CoV-2 S-RBD Nb, Nb61, gene was fused with the ALP gene sequences via a flexible linker. Recombinant cloning was used to yield a recombinant prokaryotic expression plasmid, Nb61-ALP-His. The Nb61-ALP-His construct was transformed into E. coli BL21(DE3) and expressed in bacteria. Both Nb61 properties and ALP enzymatic activity were validated by colorimetric and fluorometric analysis. FEIA was optimized and established on the basis of the Nb61-ALP fusion protein. The detection limit of the FEIA was 3.18 ng/mL, with a linear range of 1.9-62.5 ng/mL. Comparison with a commercial kit indicated the reliability of the Nb61-ALP fusion-protein-based FEIA for monitoring the SARS-CoV-2 spike protein. This study highlights the potential of Nb-based enzyme immunoassays as a valuable tool for the rapid and accurate detection of SARS-CoV-2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Stomatology, Hospital of Stomatology/Guangxi Key Laboratory of Nanobody Research/Guangxi Nanobody Engineering Research Center/School of Basic Medical Sciences/Affiliated Tumor Hospital, Guangxi Medical Univer…
- Department of Otolaryngology Head and Neck Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi 530021, China.
- Medical College, Guangxi University of Science and Technology, Liuzhou, Guangxi 545005, China.
- Department of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.
- Sydney Dental School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales 2006, Australia.
- Charles Perkins Centre, The University of Sydney, Camperdown, New South Wales 2006, Australia.
ORCID-Profile: Qianling Su, Chun Xu
Förderung
- Specific Research Project of Guangxi for Research Bases and Talents
- National Natural Science Foundation of China
- Guangxi Key Laboratory of Nanobody Research
- Guangxi Zhuang Autonomous Region Nanobody Engineering Research Center
Zitieren
APA
Liu, H., Su, Q., Duan, S., Huang, X., Yang, X., Liu, A., Liu, S., Xu, C., & Lu, X. (2024). Development of a Nanobody–Alkaline Phosphatase Fusion Protein for Detection of SARS-CoV-2 Spike Protein in a Fluorescence Enzyme Immunoassay. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.4c04799
Vancouver
Liu H, Su Q, Duan S, Huang X, Yang X, Liu A, et al. Development of a Nanobody–Alkaline Phosphatase Fusion Protein for Detection of SARS-CoV-2 Spike Protein in a Fluorescence Enzyme Immunoassay. Analytical Chemistry. 2024. doi:10.1021/acs.analchem.4c04799
BibTeX
@article{Liu2024,
author = {Liu, Heng and Su, Qianling and Duan, Siliang and Huang, Xianing and Yang, Xiaomei and Liu, Aiqun and Liu, Shiquan and Xu, Chun and Lu, Xiaoling},
title = {Development of a Nanobody–Alkaline Phosphatase Fusion Protein for Detection of SARS-CoV-2 Spike Protein in a Fluorescence Enzyme Immunoassay},
journal = {Analytical Chemistry},
year = {2024},
doi = {10.1021/acs.analchem.4c04799}
}
EUVIMED